<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font16">for </span>
   <span class="font16">with </span>
   <span class="font14">coronavirus </span>
   <span class="font13">inhibitors </span>
   <span class="font13">that </span>
   <span class="font13">respiratory </span>
   <span class="font13">[]. </span>
   <span class="font13">MERS-CoV </span>
   <span class="font12">inhibitor </span>
   <span class="font12">SARS-CoV </span>
   <span class="font12">against </span>
   <span class="font12">syndrome </span>
   <span class="font12">are </span>
   <span class="font12">human </span>
   <span class="font12">replication </span>
   <span class="font12">was </span>
   <span class="font12">The </span>
   <span class="font12">viral </span>
   <span class="font12">antiviral </span>
   <span class="font12">protease </span>
   <span class="font11">virus </span>
   <span class="font11">activity </span>
   <span class="font11">SARS </span>
   <span class="font11">were </span>
   <span class="font11">have </span>
   <span class="font11">infection </span>
   <span class="font11">inhibit </span>
   <span class="font11">Med. </span>
   <span class="font11">acute </span>
   <span class="font11">{background </span>
   <span class="font11">Fig. </span>
   <span class="font11">severe </span>
   <span class="font11">entry </span>
   <span class="font11">East </span>
   <span class="font11">which </span>
   <span class="font11">been </span>
   <span class="font11">coronaviruses </span>
   <span class="font11">CLpro </span>
   <span class="font11">reported </span>
   <span class="font11">treatment </span>
   <span class="font11">Chem. </span>
   <span class="font11">Middle </span>
   <span class="font11">from </span>
   <span class="font11">protein </span>
   <span class="font11">synthesis </span>
   <span class="font11">broad-spectrum </span>
   <span class="font11">margin </span>
   <span class="font11">potent </span>
   <span class="font11">CoVs </span>
   <span class="font11">Virol. </span>
   <span class="font11">also </span>
   <span class="font11">both </span>
   <span class="font11">has </span>
   <span class="font11">host </span>
   <span class="font11">novel </span>
   <span class="font11">{border-style </span>
   <span class="font11">PLpro </span>
   <span class="font11">RNA </span>
   <span class="font11">showed </span>
   <span class="font11">target </span>
   <span class="font10">(.) </span>
   <span class="font10">cell </span>
   <span class="font10">drugs </span>
   <span class="font10">its </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(), </span>
   <span class="font10">Infect. </span>
   <span class="font10">acid </span>
   <span class="font10">inhibited </span>
   <span class="font10">not </span>
   <span class="font10">other </span>
   <span class="font10">used </span>
   <span class="font10">agents </span>
   <span class="font10">interferon </span>
   <span class="font10">into </span>
   <span class="font10">potential </span>
   <span class="font10">such </span>
   <span class="font10">they </span>
   <span class="font10">compound </span>
   <span class="font10">patients </span>
   <span class="font10">Dis. </span>
   <span class="font10">Figure </span>
   <span class="font10">cells </span>
   <span class="font10">compounds </span>
   <span class="font10">including </span>
   <span class="font10">targeting </span>
   <span class="font10">these </span>
   <span class="font10">Res. </span>
   <span class="font10">but </span>
   <span class="font10">development </span>
   <span class="font10">identified </span>
   <span class="font10">important </span>
   <span class="font10">proteins </span>
   <span class="font10">(Fig. </span>
   <span class="font10">CoV </span>
   <span class="font10">Table </span>
   <span class="font10">These </span>
   <span class="font10">all </span>
   <span class="font10">anti-viral </span>
   <span class="font10">clinical </span>
   <span class="font10">drug </span>
   <span class="font10">fusion </span>
   <span class="font10">infections </span>
   <span class="font10">inhibition </span>
   <span class="font10">new </span>
   <span class="font10">vitro </span>
   <span class="font10">HCoV-OC </span>
   <span class="font10">[], </span>
   <span class="font10">activities </span>
   <span class="font10">combination </span>
   <span class="font10">may </span>
   <span class="font10">papain-like </span>
   <span class="font10">receptor </span>
   <span class="font10">ribavirin </span>
   <span class="font10">than </span>
   <span class="font10">through </span>
   <span class="font10">However, </span>
   <span class="font10">can </span>
   <span class="font10">could </span>
   <span class="font10">early </span>
   <span class="font10">effect </span>
   <span class="font10">inhibits </span>
   <span class="font10">proteases </span>
   <span class="font10">response </span>
   <span class="font10">screening </span>
   <span class="font10">this </span>
   <span class="font10">Agents </span>
   <span class="font10">HCoV-E </span>
   <span class="font10">MERS </span>
   <span class="font10">Neurotransmitter </span>
   <span class="font10">This </span>
   <span class="font10">agent </span>
   <span class="font10">anti-CoV </span>
   <span class="font10">discovery </span>
   <span class="font10">effective </span>
   <span class="font10">inhibitory </span>
   <span class="font10">mycophenolic </span>
   <span class="font10">range </span>
   <span class="font10">signaling </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">values </span>
   <span class="font10">viruses </span>
   <span class="font10">(&amp;gt;) </span>
   <span class="font10">Chemother. </span>
   <span class="font10">MERS-CoVs </span>
   <span class="font10">Sci. </span>
   <span class="font10">active </span>
   <span class="font10">another </span>
   <span class="font10">biological </span>
   <span class="font10">evaluation </span>
   <span class="font10">four </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">px; </span>
   <span class="font10">site </span>
   <span class="font10">spike </span>
   <span class="font10">structure </span>
   <span class="font10">study </span>
   <span class="font10">{font-family </span>
   <span class="font10">SARS- </span>
   <span class="font10">and/or </span>
   <span class="font10">any </span>
   <span class="font10">based </span>
   <span class="font10">clathrin-mediated </span>
   <span class="font10">cysteine </span>
   <span class="font10">different </span>
   <span class="font10">enzyme </span>
   <span class="font10">font-size </span>
   <span class="font10">found </span>
   <span class="font10">further </span>
   <span class="font10">genomic </span>
   <span class="font10">high </span>
   <span class="font10">involved </span>
   <span class="font10">low </span>
   <span class="font10">more </span>
   <span class="font10">pathway </span>
   <span class="font10">research </span>
   <span class="font10">series </span>
   <span class="font10">shown </span>
   <span class="font10">studies </span>
   <span class="font10">therapeutic </span>
   <span class="font10">therapy </span>
   <span class="font10">various </span>
   <span class="font10">well </span>
   <span class="font10">μM, </span>
   <span class="font10">μM. </span>
   <span class="font10">(nsp), </span>
   <span class="font10">Acad. </span>
   <span class="font10">Although </span>
   <span class="font10">Compound </span>
   <span class="font10">For </span>
   <span class="font10">MERS-CoV, </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">They </span>
   <span class="font10">about </span>
   <span class="font10">acts </span>
   <span class="font10">antivirals </span>
   <span class="font10">binding </span>
   <span class="font10">block </span>
   <span class="font10">control </span>
   <span class="font10">derivatives </span>
   <span class="font10">discovered </span>
   <span class="font10">double; </span>
   <span class="font10">endocytosis </span>
   <span class="font10">example, </span>
   <span class="font10">first </span>
   <span class="font10">had </span>
   <span class="font10">hydrochloride </span>
   <span class="font10">main </span>
   <span class="font10">micromolar </span>
   <span class="font10">moderate </span>
   <span class="font10">molecules </span>
   <span class="font10">monophosphate </span>
   <span class="font10">mutant </span>
   <span class="font10">only </span>
   <span class="font10">scaffold </span>
   <span class="font10">small </span>
   <span class="font10">specific </span>
   <span class="font10">those </span>
   <span class="font10">virus, </span>
   <span class="font10">DNA </span>
   <span class="font10">Ebola </span>
   <span class="font10">Elsevier </span>
   <span class="font10">HCoV-NL </span>
   <span class="font10">Lett. </span>
   <span class="font10">MERS- </span>
   <span class="font10">Natl. </span>
   <span class="font10">Nipah </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">SARS-and </span>
   <span class="font10">SARS-coronavirus </span>
   <span class="font10">al. </span>
   <span class="font10">analogs </span>
   <span class="font10">approach </span>
   <span class="font10">approved </span>
   <span class="font10">associated </span>
   <span class="font10">available </span>
   <span class="font10">between </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad </span>
   <span class="font10">cellular </span>
   <span class="font10">coronaviruses, </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">decahydroisoquinoline </span>
   <span class="font10">developing </span>
   <span class="font10">did </span>
   <span class="font10">dipeptidyl </span>
   <span class="font10">displayed </span>
   <span class="font10">during </span>
   <span class="font10">emerging </span>
   <span class="font10">enzymes </span>
   <span class="font10">evaluated </span>
   <span class="font10">hepatitis </span>
   <span class="font10">identification </span>
   <span class="font10">infections. </span>
   <span class="font10">influenza </span>
   <span class="font10">interactions </span>
   <span class="font10">library </span>
   <span class="font10">life </span>
   <span class="font10">mechanism </span>
   <span class="font10">membrane </span>
   <span class="font10">natural </span>
   <span class="font10">nucleic </span>
   <span class="font10">outcome </span>
   <span class="font10">peptide </span>
   <span class="font10">replicase </span>
   <span class="font10">respectively. </span>
   <span class="font10">resulting </span>
   <span class="font10">see </span>
   <span class="font10">serine </span>
   <span class="font10">sialic </span>
   <span class="font10">significant </span>
   <span class="font10">silvestrol </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">structural </span>
   <span class="font10">suggest </span>
   <span class="font10">synthesis, </span>
   <span class="font10">type </span>
   <span class="font10">viruses, </span>
   <span class="font10">vivo </span>
   <span class="font10">while </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(CC) </span>
   <span class="font10">(ii) </span>
   <span class="font10">ACE </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Biol. </span>
   <span class="font10">C-like </span>
   <span class="font10">COVID- </span>
   <span class="font10">CoVs. </span>
   <span class="font10">Coimbatore, </span>
   <span class="font10">Coronaviruses </span>
   <span class="font10">HCV </span>
   <span class="font10">Professor </span>
   <span class="font10">Recently, </span>
   <span class="font10">Research </span>
   <span class="font10">Structure </span>
   <span class="font10">University </span>
   <span class="font10">University, </span>
   <span class="font10">X-ray </span>
   <span class="font10">action, </span>
   <span class="font10">addition </span>
   <span class="font10">analog </span>
   <span class="font10">animal </span>
   <span class="font10">anti-MERS-CoV </span>
   <span class="font10">assay </span>
   <span class="font10">bold </span>
   <span class="font10">cathepsin </span>
   <span class="font10">cause </span>
   <span class="font10">cells. </span>
   <span class="font10">centre </span>
   <span class="font10">chronic </span>
   <span class="font10">class </span>
   <span class="font10">coronaviral </span>
   <span class="font10">coronavirus: </span>
   <span class="font10">courier; </span>
   <span class="font10">cycle </span>
   <span class="font10">derivative </span>
   <span class="font10">design </span>
   <span class="font10">design, </span>
   <span class="font10">designed </span>
   <span class="font10">developed </span>
   <span class="font10">domain </span>
   <span class="font10">dual </span>
   <span class="font10">effects </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">enveloped </span>
   <span class="font10">essential </span>
   <span class="font10">excellent </span>
   <span class="font10">functional </span>
   <span class="font10">genome </span>
   <span class="font10">highly </span>
   <span class="font10">his </span>
   <span class="font10">humans </span>
   <span class="font10">immune </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">inhibitorsBioorg. </span>
   <span class="font10">interferons </span>
   <span class="font10">isolated </span>
   <span class="font10">kinase </span>
   <span class="font10">known </span>
   <span class="font10">major </span>
   <span class="font10">management </span>
   <span class="font10">molecule </span>
   <span class="font10">non-structural </span>
   <span class="font10">nsp </span>
   <span class="font10">numerous </span>
   <span class="font10">observed </span>
   <span class="font10">outbreak </span>
   <span class="font10">oxygen </span>
   <span class="font10">peptidomimetic </span>
   <span class="font10">primary </span>
   <span class="font10">produce </span>
   <span class="font10">promising </span>
   <span class="font10">properties </span>
   <span class="font10">protein, </span>
   <span class="font10">pt;} </span>
   <span class="font10">received </span>
   <span class="font10">recent </span>
   <span class="font10">resource </span>
   <span class="font10">retrospective </span>
   <span class="font10">ritonavir </span>
   <span class="font10">role </span>
   <span class="font10">selective </span>
   <span class="font10">sequence </span>
   <span class="font10">small-molecule </span>
   <span class="font10">species </span>
   <span class="font10">stages </span>
   <span class="font10">suggested </span>
   <span class="font10">suggesting </span>
   <span class="font10">their </span>
   <span class="font10">therapeutics </span>
   <span class="font10">three </span>
   <span class="font10">treat </span>
   <span class="font10">treated </span>
   <span class="font10">trials </span>
   <span class="font10">use </span>
   <span class="font10">via </span>
   <span class="font10">who </span>
   <span class="font10">working </span>
  </p>
 </body>
</html>
